Trial Profile
Phase I trial of KEA 0447 for the treatment of overactive bladder.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2013
Price :
$35
*
At a glance
- Drugs KEA 0447 (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical; Kyorin Pharmaceutical
- 22 Oct 2013 New trial record